冠状动脉微栓塞:从床边到长椅,然后回到床边
Gerd Heusch1, Petra Kleinbongard, Dirk Böse
1Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany. gerd.heusch@uk-essen.de
Circulation
|November 4, 2009
概括
冠状动脉微栓塞,通常来自斑块破裂,导致心脏损伤. 像他类药物和吸入装置这样的治疗可以减轻这些影响,改善急性心肌梗塞的结果.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
背景情况:
- 冠状动脉微栓塞是由斑块侵蚀/破裂引起的,与急性冠状动脉综合征和穿皮冠状动脉干预有关.
- 其后果包括微型心脏病发作,炎症,收缩功能障碍和冠状动脉储备减少.
研究的目的:
- 审查冠状动脉微栓塞的机制,后果,检测和预防策略.
主要方法:
- 关于自发性和催血性冠状动脉微栓塞的文献综述.
- 讨论诊断工具,如冠心内多普勒和晚期增强核磁共振.
- 保护性药物和基于设备的干预措施的分析.
主要成果:
- 微栓塞可以通过冠心内多普勒可视化,而微心脏病通过MRI可视化.
- 类药物,抗血小板剂和血管扩张剂在干预前给药时提供保护.
- 远距离保护装置显示出有限的临床益处,除了在软静脉移植外.
结论:
- 吸气装置有效地降低了血栓负担,并改善了急性心肌梗塞的输液.
- 药理和干预策略对于管理冠状动脉微栓塞及其后果至关重要.
相关概念视频
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Pulmonary Embolism I: Introduction
1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749


